Upward adjustment of Auriga's outlook for 2008 from a profit before tax of DKK 260-310 million to DKK 440-490 million

Company announcement no. 12/2008

June 24, 2008


Upward adjustment of Auriga's outlook for 2008 
from a profit before tax of DKK 260-310 million to DKK 440-490 million


The strong development in revenue and earnings achieved by Auriga's subsidiary
Cheminova in Q1 2008 has continued in Q2. The increase is driven by the most
important product, glyphosate, with an increase in demand and a reduction in
supply leading to substantial price increases relative to previous years. The
market situation for glyphosate is expected to normalise during 2009, after
which market prices are expected to start declining. Sales of new products and
the acquisition of a 50 per cent stake in Stähler are seeing satisfactory
developments and are contributing to growth as expected. 

For the financial year as a whole, Cheminova is expecting revenue of about DKK
5.5 billion against about DKK 5.2 billion as released in the interim report for
Q1, and a profit before tax of DKK 450-500 million against earlier expectations
of DKK 250-300 million. 

Auriga's property in Taastrup has been put on the market at a price which, in
light of the declining prices in the property market, is approx. DKK 20 million
below the carrying amount, for which reason the property is written down by
DKK 20 million. 

Auriga now expects revenue for the year of about DKK 5.5 billion against about
DKK 5.2 billion as released in the interim report for Q1, with a profit before
tax of DKK 440-490 million against earlier expectations of DKK 260-310 million. 

Auriga's interim report for H1 will be published on August 20, 2008.



AURIGA INDUSTRIES A/S		

Ole Steen Andersen		
Chairman of the Board of Directors	

Bjørn Albinus
President and CEO

Further information:
Auriga Investor Relations
Tel. +45 7010 7030